🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07705984
Starting soon Not applicable

Kinesio Taping for Neurogenic Bowel Dysfunction in Spinal Cord Injury

NCT07705984 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-07-30
Last updated
2026-07-15

Condition(s) studied

Neurogenic Bowel DysfunctionSpinal Cord Injury

Investigational drug(s) / intervention(s)

Kinesio TapingRoutine Bowel Management Program

Kinesio Taping: Kinesio Taping will be applied to the lower abdominal and lumbosacral regions three times per week for 4 weeks. The tape will remain in place for 2 days and will be removed before the next treatment session. A star-shaped correction technique will be applied to the lumbosacral region with 25%-50% tension. An I-shaped correction technique will be applied to the lower abdominal region between the right and left anterior superior iliac spines. No tension will be applied to the ends of the tape.

Routine Bowel Management Program: Participants will receive an individualized routine bowel management program based on their clinical condition for 4 weeks. The program may include scheduled bowel care, dietary and fluid recommendations, appropriate positioning, physical activity, abdominal massage, rectal evacuation techniques, suppositories, enemas, and oral or rectal laxatives when clinically indicated. Participants will be instructed not to change their usual dietary habits during the study period.

Study summary

Neurogenic bowel dysfunction is a common complication of spinal cord injury and may cause constipation, difficulty with defecation, prolonged bowel care, incomplete evacuation, fecal incontinence, and reduced quality of life. This randomized controlled trial aims to evaluate the effectiveness of Kinesio Taping added to a routine bowel management program in adults with spinal cord injury and upper motor neuron-type neurogenic bowel dysfunction.

Thirty participants will be randomly assigned to one of two parallel groups. The control group will receive a routine bowel management program, while the intervention group will receive Kinesio Taping in addition to the routine bowel management program. Kinesio Taping will be applied to the lower abdominal and lumbosacral regions three times per week for 4 weeks.

The primary outcome will be defecation frequency recorded using a 7-day bowel diary. Secondary outcomes will include stool consistency, defecation duration, perceived constipation severity, neurogenic bowel dysfunction severity, and health-related quality of life. Assessments will be performed before and after the 4-week intervention.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18 years or older with traumatic or nontraumatic spinal cord injury * Neurological level of injury at T12 or above * Upper motor neuron-type neurogenic bowel dysfunction * Duration of spinal cord injury longer than 6 months * Ability and willingness to provide written informed consent Exclusion Criteria: * Age younger than 18 years * Neurological level of injury below T12 * Gastrointestinal disease diagnosed before the spinal cord injury, including irritable bowel syndrome or inflammatory bowel disease * History of conservative treatment for neurogenic bowel dysfunction within the previous 6 months * Colostomy or history of bowel surgery * Neurological disease other than spinal cord injury that may cause gastrointestinal or anal sphincter dysfunction * Cognitive impairment that may interfere with participation in the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Pamukkale University Hospital Denizli Denizli

More Pamukkale University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07705984 on ClinicalTrials.gov ↗ ← All trials in Turkey